Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma

BACKGROUND: Glypican-3 (GPC3) is a newly identified target molecule for the early diagnosis of hepatocellular carcinoma (HCC), while targeted inhibition of GPC3 signaling may help to control the proliferation and metastasis of HCC cells. The purpose of this study was to prepare the anti-GPC3 nanobod...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Lijie, Teng, Qiao, Chen, Qi, Zhang, Fuchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125335/
https://www.ncbi.nlm.nih.gov/pubmed/32280214
http://dx.doi.org/10.2147/IJN.S235058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125335/
https://www.ncbi.nlm.nih.gov/pubmed/32280214
http://dx.doi.org/10.2147/IJN.S235058

Ejemplares similares